Plain-English translation of NCT07363382 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing two new types of imaging scans—called and —that are designed to help doctors detect and map prostate cancer more effectively. These scans work by using a radioactive tracer that highlights cancer cells in your body, similar to other advanced imaging techniques doctors already use. The study will compare how well these new scans work compared to an existing imaging method called PSMA PET.
Some prostate cancers don't show up well on current imaging tests, which can make it harder for doctors to find all the cancer and plan the best treatment. This study is exploring whether these new imaging approaches can fill that gap and help catch cancers that might otherwise be missed.
You likely qualify if…
You likely don't qualify if…
You will receive two separate intravenous injections of a small amount of radioactive tracer, followed by imaging scans to visualize prostate cancer in your body. Each injection is a single dose given as part of the scan procedure. The study involves a small number of participants (about 6 people total) and is being conducted at a hospital in China.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
China
Phase
Safety & dosing / Early efficacy
Sponsor
First Affiliated Hospital of Fujian Medical University
Enrollment target
~6 participants
Started
December 2025
Primary completion
December 2026
Age range
18 Years – 90 Years
Sex
Male only
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Weibing Miao, MD
First Affiliated Hospital of Fujian Medical University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.